{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:39:40Z","timestamp":1793727580004,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770714"],"award-info":[{"award-number":["81770714"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470947"],"award-info":[{"award-number":["81470947"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570622"],"award-info":[{"award-number":["81570622"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Immunoglobulin A nephropathy (IgAN) is identified as mesangial IgA deposition and is usually accompanied by other immunofluorescence deposits. The impact of immunofluorescent features in IgAN patients, however, remains unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Baseline clinicopathologic parameters and renal outcomes of 337 patients diagnosed with IgAN between January 2009 and December 2015 were analyzed. We then categorized these patients into four groups: without immunofluorescence deposits, mesangial-only, mesangial and glomerular capillary loops (GCLs), and GCLs-only. The study endpoint was end-stage kidney disease (ESKD) or a\u2009\u2265\u200950% decline in the estimated glomerular filtration rate (eGFR). Kaplan\u2013Meier and Cox regression analyses were performed to calculate renal survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 337 IgAN patients, women comprised 57.0%. Compared to patients with IgA deposition in the mesangial-only group, patients with IgA deposition in the mesangial +GCLs group were much heavier, and exhibited higher systolic blood pressure, lower serum IgG levels, and heavier proteinuria (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Patients with IgG deposition in the mesangial +GCLs group presented with higher levels of cholesterol, heavier proteinuria than IgG deposition in the mesangial-only group (both <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Compared with the mesangial-only group exhibiting C3 deposits, patients in the mesangial +GCLs group with C3 deposition had a higher systolic blood pressure (<jats:italic>P<\/jats:italic>\u2009=\u20090.028). A total of 38 patients (11.3%) continued to the study endpoint after a median follow-up time of 63.5\u2009months (range,49.8\u201381.4). Kaplan\u2013Meier analysis and Cox regression analysis showed that C1q deposition in the mesangial +GCLs group predicted a poor renal prognosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>IgA and IgG deposits in the mesangial region and GCLs were associated with more unfavorable clinical and histopathologic findings in IgAN patients. C1q deposition in the mesangial region and GCLs predicted a poor renal prognosis. However, the impact of the pattern of immunofluorescence deposits on renal outcomes remains to be proven by further investigation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-021-02237-w","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T12:18:20Z","timestamp":1611922700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Immunofluorescence deposits in the mesangial area and glomerular capillary loops did not affect the prognosis of immunoglobulin a nephropathy except C1q:a single-center retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Lingzhi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6040-5323","authenticated-orcid":false,"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"issue":"3","key":"2237_CR1","doi-asserted-by":"publisher","first-page":"e91756","DOI":"10.1371\/journal.pone.0091756","volume":"9","author":"T Moriyama","year":"2014","unstructured":"Moriyama T, Tanaka K, Iwasaki C, Oshima Y, Ochi A, Kataoka H, Itabashi M, Takei T, Uchida K, Nitta K. Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS One. 2014;9(3):e91756.","journal-title":"PLoS One"},{"key":"2237_CR2","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","volume":"2","author":"KN Lai","year":"2016","unstructured":"Lai KN, Tang SC, Schena FP, Novak J, Tomino Y, Fogo AB, Glassock RJ. IgA nephropathy. Nat Rev Dis Primers. 2016;2:16001.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"2237_CR3","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1681\/ASN.2010040355","volume":"22","author":"F Berthoux","year":"2011","unstructured":"Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L. Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol. 2011;22(4):752\u201361.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2237_CR4","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","volume":"27","author":"W Le","year":"2012","unstructured":"Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant. 2012;27(4):1479\u201385.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"2237_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrneph.2017.67","volume":"13","author":"G Markowitz","year":"2017","unstructured":"Markowitz G. Glomerular disease: updated Oxford classification of IgA nephropathy: a new MEST-C score. Nat Rev Nephrol. 2017;13(7):385\u20136.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"2237_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10157-018-1619-6","volume":"23","author":"R Katafuchi","year":"2019","unstructured":"Katafuchi R, Nagae H, Masutani K, Tsuruya K, Mitsuiki K. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy. Clin Exp Nephrol. 2019;23(2):169\u201381.","journal-title":"Clin Exp Nephrol"},{"key":"2237_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.intimp.2018.10.044","volume":"66","author":"D Liu","year":"2019","unstructured":"Liu D, You J, Liu Y, Tang X, Tan X, Xia M, Wu L, Chen G, He L, Zhu X, Liu H. Serum immunoglobulin G provides early risk prediction in immunoglobulin a nephropathy. Int Immunopharmacol. 2019;66:13\u20138.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"2237_CR8","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ckd EPI. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"12","key":"2237_CR9","first-page":"1381","volume":"132","author":"SK Parai","year":"1985","unstructured":"Parai SK, Ghose T. IgA nephropathy in adults: immunohistologic findings and clinical course. Can Med Assoc J. 1985;132(12):1381\u20134.","journal-title":"Can Med Assoc J"},{"key":"2237_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000409745","volume":"40","author":"A Vangelista","year":"1984","unstructured":"Vangelista A, Frasca GM, Mondini S, Bonomini V. Idiopathic IgA mesangial nephropathy: immunohistological features. Contrib Nephrol. 1984;40:167\u201373.","journal-title":"Contrib Nephrol"},{"issue":"5","key":"2237_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0272-6386(87)80143-9","volume":"9","author":"M Yoshimura","year":"1987","unstructured":"Yoshimura M, Kida H, Abe T, Takeda S, Katagiri M, Hattori N. Significance of IgA deposits on the glomerular capillary walls in IgA nephropathy. Am J Kidney Dis. 1987;9(5):404\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2237_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000183000","volume":"34","author":"Y Kobayashi","year":"1983","unstructured":"Kobayashi Y, Tateno S, Hiki Y, Shigematsu H. IgA nephropathy: prognostic significance of proteinuria and histological alterations. Nephron. 1983;34(3):146\u201353.","journal-title":"Nephron"},{"issue":"228","key":"2237_CR13","first-page":"363","volume":"59","author":"G D'Amico","year":"1986","unstructured":"D'Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano di Belgioioso G, Imbasciati E, Ragni A, Bertoli S, Fogazzi G, et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med. 1986;59(228):363\u201378.","journal-title":"Q J Med"},{"issue":"8","key":"2237_CR14","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1093\/ndt\/gfq812","volume":"26","author":"SS Bellur","year":"2011","unstructured":"Bellur SS, Troyanov S, Cook HT, Roberts IS, A.N.N. Working Group of International Ig, S. Renal Pathology, Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. Nephrol Dial Transplant. 2011;26(8):2533\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2237_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1053\/j.ajkd.2011.05.033","volume":"58","author":"J Floege","year":"2011","unstructured":"Floege J. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches? Am J Kidney Dis. 2011;58(6):992\u20131004.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2237_CR16","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1053\/ajkd.1998.v31.pm9631840","volume":"31","author":"C Nieuwhof","year":"1998","unstructured":"Nieuwhof C, Kruytzer M, Frederiks P, van Breda Vriesman PJ. Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy. Am J Kidney Dis. 1998;31(6):962\u201370.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2237_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10157-012-0660-0","volume":"17","author":"Y Wada","year":"2013","unstructured":"Wada Y, Ogata H, Takeshige Y, Takeshima A, Yoshida N, Yamamoto M, Ito H, Kinugasa E. Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy. Clin Exp Nephrol. 2013;17(1):73\u201382.","journal-title":"Clin Exp Nephrol"},{"issue":"7","key":"2237_CR18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/modpathol.2016.77","volume":"29","author":"DH Shin","year":"2016","unstructured":"Shin DH, Lim BJ, Han IM, Han SG, Kwon YE, Park KS, Lee MJ, Oh HJ, Park JT, Han SH, Kang SW, Yoo TH. Glomerular IgG deposition predicts renal outcome in patients with IgA nephropathy. Mod Pathol. 2016;29(7):743\u201352.","journal-title":"Mod Pathol"},{"issue":"7","key":"2237_CR19","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/ndt\/gfx238","volume":"33","author":"AS Alvarado","year":"2018","unstructured":"Alvarado AS, Andeen NK, Brodsky S, Hinton A, Nadasdy T, Alpers CE, Blosser C, Najafian B, Rovin BH. Location of glomerular immune deposits, not codeposition of immunoglobulin G, influences definitive renal outcomes in immunoglobulin a nephropathy. Nephrol Dial Transplant. 2018;33(7):1168\u201375.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2237_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/BF00858525","volume":"3","author":"CY Lin","year":"1989","unstructured":"Lin CY, Chen CH, Lee PP. In vitro B-lymphocyte switch disturbance from IgM into IgG in IgM mesangial nephropathy. Pediatr Nephrol. 1989;3(3):254\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"2237_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000183986","volume":"44","author":"CY Lin","year":"1986","unstructured":"Lin CY, Chu CM. Studies of circulating immune complexes and lymphocyte subpopulations in childhood IgM mesangial nephropathy. Nephron. 1986;44(3):198\u2013203.","journal-title":"Nephron"},{"issue":"3","key":"2237_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1681\/ASN.2012020187","volume":"24","author":"D Strassheim","year":"2013","unstructured":"Strassheim D, Renner B, Panzer S, Fuquay R, Kulik L, Ljubanovic D, Holers VM, Thurman JM. IgM contributes to glomerular injury in FSGS. J Am Soc Nephrol. 2013;24(3):393\u2013406.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2237_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ki.2015.153","volume":"88","author":"JL Platt","year":"2015","unstructured":"Platt JL, Cascalho M. IgM in the kidney: a multiple personality disorder. Kidney Int. 2015;88(3):439\u201341.","journal-title":"Kidney Int"},{"issue":"3","key":"2237_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10157-018-1651-6","volume":"23","author":"C Heybeli","year":"2019","unstructured":"Heybeli C, Oktan MA, Yildiz S, Arda HU, Unlu M, Cavdar C, Sifil A, Celik A, Sarioglu S, Camsari T. Clinical significance of mesangial IgM deposition in patients with IgA nephropathy. Clin Exp Nephrol. 2019;23(3):371\u20139.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"2237_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/PAP.0000000000000134","volume":"24","author":"T Al Hussain","year":"2017","unstructured":"Al Hussain T, Hussein MH, Al Mana H, Akhtar M. Pathophysiology of IgA nephropathy. Adv Anat Pathol. 2017;24(1):56\u201362.","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"2237_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000443415","volume":"41","author":"Y Caliskan","year":"2016","unstructured":"Caliskan Y, Ozluk Y, Celik D, Oztop N, Aksoy A, Ucar AS, Yazici H, Kilicaslan I, Sever MS. The clinical significance of uric acid and complement activation in the progression of IgA nephropathy. Kidney Blood Press Res. 2016;41(2):148\u201357.","journal-title":"Kidney Blood Press Res"},{"issue":"7","key":"2237_CR27","doi-asserted-by":"publisher","first-page":"e40495","DOI":"10.1371\/journal.pone.0040495","volume":"7","author":"SJ Kim","year":"2012","unstructured":"Kim SJ, Koo HM, Lim BJ, Oh HJ, Yoo DE, Shin DH, Lee MJ, Doh FM, Park JT, Yoo TH, Kang SW, Choi KH, Jeong HJ, Han SH. Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS One. 2012;7(7):e40495.","journal-title":"PLoS One"},{"issue":"3","key":"2237_CR28","first-page":"190","volume":"2","author":"H Nasri","year":"2013","unstructured":"Nasri H, Sajjadieh S, Mardani S, Momeni A, Merikhi A, Madihi Y, Ghiessari A, Emami Naieni A. Correlation of immunostaining findings with demographic data and variables of Oxford classification in IgA nephropathy. J Nephropathol. 2013;2(3):190\u20135.","journal-title":"J Nephropathol"},{"issue":"12","key":"2237_CR29","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1093\/ndt\/gfz161","volume":"35","author":"S Park","year":"2020","unstructured":"Park S, Kim HW, Park JT, Chang TI, Kang EW, Ryu DR, Yoo TH, Chin HJ, Jeong HJ, Kang SW, Lim BJ, Han SH. Relationship between complement deposition and the Oxford classification score and their combined effects on renal outcome in immunoglobulin A nephropathy. Nephrol Dial Transplant. 2020;35(12):2103\u201337.","journal-title":"Nephrol Dial Transplant."},{"issue":"7","key":"2237_CR30","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/ndt\/gfs262","volume":"28","author":"I Ohsawa","year":"2013","unstructured":"Ohsawa I, Kusaba G, Ishii M, Sato N, Inoshita H, Onda K, Hashimoto A, Nagamachi S, Suzuki H, Shimamoto M, Ohi H, Horikoshi S, Tomino Y. Extraglomerular C3 deposition and metabolic impacts in patients with IgA nephropathy. Nephrol Dial Transplant. 2013;28(7):1856\u201364.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2237_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/path.1711770214","volume":"177","author":"AO Muda","year":"1995","unstructured":"Muda AO, Feriozzi S, Rahimi S, Faraggiana T. Spatial arrangement of IgA and C3 as a prognostic indicator of IgA nephropathy. J Pathol. 1995;177(2):201\u20138.","journal-title":"J Pathol"},{"issue":"1","key":"2237_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000381217","volume":"130","author":"H Nishiwaki","year":"2015","unstructured":"Nishiwaki H, Hasegawa T, Nagayama Y, Kaneshima N, Takayasu M, Hirose M, Komukai D, Inoue Y, Koiwa F, Yoshimura A. Absence of mesangial C1q deposition is associated with resolution of proteinuria and hematuria after tonsillectomy plus steroid pulse therapy for immunoglobulin a nephropathy. Nephron. 2015;130(1):1\u20137.","journal-title":"Nephron"},{"issue":"2","key":"2237_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5414\/CN107854","volume":"80","author":"HJ Lee","year":"2013","unstructured":"Lee HJ, Choi SY, Jeong KH, Sung JY, Moon SK, Moon JY, Lee SH, Lee TW, Ihm CG. Association of C1q deposition with renal outcomes in IgA nephropathy. Clin Nephrol. 2013;80(2):98\u2013104.","journal-title":"Clin Nephrol"},{"issue":"9","key":"2237_CR34","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1080\/0886022X.2016.1214051","volume":"38","author":"Y Liu","year":"2016","unstructured":"Liu Y, Hu Q, Shen P, Tang L, Yuan G, Zhou Y, Chai H. Clinical and pathological analysis of IgA nephropathy with chronic renal failure. Ren Fail. 2016;38(9):1347\u201352.","journal-title":"Ren Fail"},{"issue":"5","key":"2237_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/ndt\/gfv403","volume":"31","author":"Z He","year":"2016","unstructured":"He Z, Zhang Y, Cao M, Ma R, Meng H, Yao Z, Zhao L, Liu Y, Wu X, Deng R, Dong Z, Bi Y, Kou J, Novakovic V, Shi J, Hao L. Increased phosphatidylserine-exposing microparticles and their originating cells are associated with the coagulation process in patients with IgA nephropathy. Nephrol Dial Transplant. 2016;31(5):747\u201359.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2237_CR36","first-page":"676","volume":"18","author":"M Haas","year":"2005","unstructured":"Haas M. Histology and immunohistology of IgA nephropathy. J Nephrol. 2005;18(6):676\u201380.","journal-title":"J Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02237-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-021-02237-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02237-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T12:21:03Z","timestamp":1611922863000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02237-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2237"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02237-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"19 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of the Second Xiangya Hospital, Central South University and was performed in accordance with the Declaration of Helsinki. We have required permission to use the medical data of all participants for a non-commercial study and obtained the written informed consent from them.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We had no conflicts of interest in this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}